Gryphon Investors related stories
All articles and analysis
Young sponsors get creative to win LP greenConner Searcy’s first fund at Trive Capital reached the finish line this summer, but not without acceding to at least one unusual demand from a limited partner that ended up investing in the $300 million buyout fund.
Aterian talks to LPs about debut fundAterian Investment Partners was founded by Michael Fieldstone, a former principal with Sun Capital Partners, in 2009, according to the firm’s web site. Aterian is led by Fieldstone, former Sun Capital principal Christopher Thomas and former Insight Equity principal Brandon Bethea.
Sun Capital spawns another new shopA new-ish firm has been talking to potential investors about its debut fund, sources told sister publication peHUB.
Gryphon Investors collects $365 mln with second bridge fundGryphon Investors has completed fundraising for its second bridge fund, sources said.
- Gryphon Investors collects $365 mln with second bridge fund
Gryphon Investors has completed fundraising for another bridge fund, sources told sister publication peHUB.
- Ex-Sun Capital, HIG Partners exec launches special situation-focused fund
A former Sun Capital Partners and H.I.G. Partners executive has launched a new special situation-focused fund with the ability to pursue various investment structures, sister publication peHUB reported.
- Gryphon Closes Sales of TrustHouse to Elior
Gryphon Investors has completed the sale of TrustHouse Services Group, a Charlotte, N.C.-based contract food service provider, to Elior SCA. Financial terms weren't announced. Gryphon invested in TrustHouse in 2008. The sale to Elicor was announced in March.
- Gryphon Investors to Sell TrustHouse
Gryphon Investors, a San Francisco-based private equity firm, will sell its stake in TrustHouse Services Group to Elior SCA, the firm announced Monday. Terms were not released. TrustHouse is a pure-play contract food service provider in the U.S.
- Synteract and Harrison Clinical Research Close Deal
Synteract, a full-service contract research organization has completed its acquisition of Harrison Clinical Research to form a new multinational business – SynteractHCR. Synteract is a portfolio company of San Francisco-based Gryphon Investors.